Logo image of GHSI

GUARDION HEALTH SCIENCES INC (GHSI) Stock Fundamental Analysis

USA - NASDAQ:GHSI - US40145Q5009 - Common Stock

3.25 USD
-0.01 (-0.31%)
Last: 10/11/2024, 8:01:54 PM
3.23 USD
-0.02 (-0.62%)
After Hours: 10/11/2024, 8:01:54 PM
Fundamental Rating

5

Overall GHSI gets a fundamental rating of 5 out of 10. We evaluated GHSI against 36 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, GHSI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GHSI had positive earnings in the past year.
In the past year GHSI has reported a negative cash flow from operations.
GHSI had negative earnings in 4 of the past 5 years.
In the past 5 years GHSI always reported negative operating cash flow.
GHSI Yearly Net Income VS EBIT VS OCF VS FCFGHSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 41.65%, GHSI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 46.34%, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 41.65%
ROE 46.34%
ROIC N/A
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
GHSI Yearly ROA, ROE, ROICGHSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K -2K -3K

1.3 Margins

GHSI has a better Profit Margin (99.10%) than 100.00% of its industry peers.
GHSI has a Gross Margin (44.84%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GHSI has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 99.1%
GM 44.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
GHSI Yearly Profit, Operating, Gross MarginsGHSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

7

2. Health

2.1 Basic Checks

GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GHSI has been increased compared to 1 year ago.
The number of shares outstanding for GHSI has been increased compared to 5 years ago.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GHSI Yearly Shares OutstandingGHSI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
GHSI Yearly Total Debt VS Total AssetsGHSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

GHSI has an Altman-Z score of -5.72. This is a bad value and indicates that GHSI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.72, GHSI is not doing good in the industry: 94.44% of the companies in the same industry are doing better.
There is no outstanding debt for GHSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.72
ROIC/WACCN/A
WACC8.73%
GHSI Yearly LT Debt VS Equity VS FCFGHSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 16.67 indicates that GHSI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 16.67, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 16.59 indicates that GHSI has no problem at all paying its short term obligations.
The Quick ratio of GHSI (16.59) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.67
Quick Ratio 16.59
GHSI Yearly Current Assets VS Current LiabilitesGHSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 154.16% over the past year.
The Revenue for GHSI has decreased by -43.45% in the past year. This is quite bad
GHSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.11% yearly.
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%

3.2 Future

Based on estimates for the next years, GHSI will show a very negative growth in Earnings Per Share. The EPS will decrease by -110.23% on average per year.
GHSI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.78% yearly.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GHSI Yearly Revenue VS EstimatesGHSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
GHSI Yearly EPS VS EstimatesGHSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.56, the valuation of GHSI can be described as very cheap.
Based on the Price/Earnings ratio, GHSI is valued cheaper than 91.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of GHSI to the average of the S&P500 Index (27.38), we can say GHSI is valued rather cheaply.
GHSI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 7.56
Fwd PE N/A
GHSI Price Earnings VS Forward Price EarningsGHSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GHSI Per share dataGHSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

GHSI's earnings are expected to decrease with -110.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 153.85%, GHSI is a good candidate for dividend investing.
The stock price of GHSI dropped by -67.14% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
GHSI's Dividend Yield is rather good when compared to the industry average which is at 5.51. GHSI pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, GHSI pays a better dividend.
Industry RankSector Rank
Dividend Yield 153.85%

5.2 History

GHSI is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
GHSI Yearly Dividends per shareGHSI Yearly Dividends per shareYearly Dividends per share 2024 1 2 3 4

5.3 Sustainability

DPN/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
GHSI Yearly Income VS Free CF VS DividendGHSI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

More info and screens

GUARDION HEALTH SCIENCES INC

NASDAQ:GHSI (10/11/2024, 8:01:54 PM)

After market: 3.23 -0.02 (-0.62%)

3.25

-0.01 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)11-14 2024-11-14/amc
Inst Owners7%
Inst Owner ChangeN/A
Ins Owners206.25%
Ins Owner Change0%
Market Cap4.39M
Analysts82.86
Price Target40.8 (1155.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 153.85%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.78%
Min Revenue beat(2)-97.77%
Max Revenue beat(2)-5.79%
Revenue beat(4)1
Avg Revenue beat(4)-25.02%
Min Revenue beat(4)-97.77%
Max Revenue beat(4)6.34%
Revenue beat(8)2
Avg Revenue beat(8)-14.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)0.43
EY13.23%
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-2.9
FCFYN/A
OCF(TTM)-2.9
OCFYN/A
SpS4.76
BVpS10.19
TBVpS10.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 41.65%
ROE 46.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 99.1%
GM 44.84%
FCFM N/A
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.67
Quick Ratio 16.59
Altman-Z -5.72
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)9.76%
Cap/Depr(5y)24.37%
Cap/Sales(3y)0.36%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.97%
OCF growth 3YN/A
OCF growth 5YN/A